Pemafibrate
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Pemafibrate, covering 2021-04-09 to 2025-12-11. Get the full timeline:
Most recent: Clinical Trial Update: A Phase III Confirmatory Study of K-877 (Pemafibrate) in Patients With Hypercholesterolemia and Statin Intolerance [Phase 3]